Works matching IS 03618609 AND DT 2022 AND VI 97 AND IP 3

Results: 31
    1
    2
    3

    Non‐coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E100, doi. 10.1002/ajh.26457
    By:
    • Jelloul, Fatima Zahra;
    • Yang, Richard K.;
    • Wang, Peng;
    • Garces, Sofia;
    • Kanagal‐Shamanna, Rashmi;
    • Ok, Chi Y.;
    • Loghavi, Sanam;
    • Routbort, Mark J.;
    • Zuo, Zhuang;
    • Yin, Cheng Cameron;
    • Floyd, Kristen;
    • Bassett, Roland L.;
    • Wierda, William G.;
    • Jain, Nitin;
    • Thompson, Philip A.;
    • Luthra, Rajyalakshmi;
    • Medeiros, Leonard Jeffrey;
    • Patel, Keyur P.
    Publication type:
    Article
    4
    5
    6
    7

    Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 329, doi. 10.1002/ajh.26451
    By:
    • Reville, Patrick K.;
    • Sasaki, Koji;
    • Kantarjian, Hagop M.;
    • Daver, Naval G.;
    • Yilmaz, Musa;
    • Dinardo, Courtney D.;
    • Short, Nicholas J.;
    • Borthakur, Gautam;
    • Pemmaraju, Naveen;
    • Mehta, Rohtesh S.;
    • Pierce, Sherry;
    • Konoplev, Sergej N.;
    • Khoury, Joseph D.;
    • Garcia‐Manero, Guillermo;
    • Konopleva, Marina Y.;
    • Jabbour, Elias;
    • Ravandi, Farhad;
    • Kadia, Tapan M.
    Publication type:
    Article
    8

    Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E113, doi. 10.1002/ajh.26450
    By:
    • Amundarain, Ane;
    • Valcárcel, Luis V.;
    • Ordoñez, Raquel;
    • Garate, Leire;
    • Miranda, Estíbaliz;
    • Cendoya, Xabier;
    • Carrasco‐Leon, Arantxa;
    • Calasanz, María José;
    • Paiva, Bruno;
    • Meydan, Cem;
    • Mason, Christopher E.;
    • Melnick, Ari;
    • Rodriguez‐Otero, Paula;
    • Martín‐Subero, José I.;
    • San Miguel, Jesús;
    • Planes, Francisco J.;
    • Prósper, Felipe;
    • Agirre, Xabier
    Publication type:
    Article
    9

    The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E117, doi. 10.1002/ajh.26449
    By:
    • Szabo, Agoston Gyula;
    • Thorsen, Jonathan;
    • Iversen, Katrine Fladeland;
    • Levring, Mette Bøegh;
    • Preiss, Birgitte;
    • Helleberg, Carsten;
    • Breinholt, Marie Fredslund;
    • Hermansen, Emil;
    • Gjerdrum, Lise Mette Rahbek;
    • Bønløkke, Søren Thorgaard;
    • Nielsen, Katrine;
    • Kjeldsen, Eigil;
    • Teodorescu, Elena Manuela;
    • Dokhi, Marveh;
    • Kurt, Eva;
    • Strandholdt, Casper Nørgaard;
    • Andersen, Mette Klarskov;
    • Vangsted, Annette Juul
    Publication type:
    Article
    10

    TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 338, doi. 10.1002/ajh.26452
    By:
    • Fejtkova, Martina;
    • Sukova, Martina;
    • Hlozkova, Katerina;
    • Skvarova Kramarzova, Karolina;
    • Rackova, Marketa;
    • Jakubec, David;
    • Bakardjieva, Marina;
    • Bloomfield, Marketa;
    • Klocperk, Adam;
    • Parackova, Zuzana;
    • Sediva, Anna;
    • Aluri, Jahnavi;
    • Novakova, Michaela;
    • Kalina, Tomas;
    • Fronkova, Eva;
    • Hrusak, Ondrej;
    • Malcova, Hana;
    • Sedlacek, Petr;
    • Liba, Zuzana;
    • Kudr, Martin
    Publication type:
    Article
    11

    HLA 1–3 antigen‐mismatched related peripheral blood stem cells transplantation using low‐dose antithymocyte globulin versus unrelated cord blood transplantation.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 311, doi. 10.1002/ajh.26446
    By:
    • Wada, Fumiya;
    • Watanabe, Mizuki;
    • Konuma, Takaaki;
    • Okabe, Motohito;
    • Kobayashi, Shinichi;
    • Uchida, Naoyuki;
    • Ikegame, Kazuhiro;
    • Tanaka, Masatsugu;
    • Sugio, Yasuhiro;
    • Mukae, Junichi;
    • Onizuka, Makoto;
    • Kawakita, Toshiro;
    • Kuriyama, Takuro;
    • Takahashi, Satoshi;
    • Fukuda, Takahiro;
    • Nakano, Nobuaki;
    • Sawa, Masashi;
    • Kimura, Takafumi;
    • Ichinohe, Tatsuo;
    • Atsuta, Yoshiko
    Publication type:
    Article
    12
    13
    14

    Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E95, doi. 10.1002/ajh.26437
    By:
    • Visentin, Andrea;
    • Mauro, Francesca Romana;
    • Cibien, Francesca;
    • Vitale, Candida;
    • Reda, Gianluigi;
    • Fresa, Alberto;
    • Ciolli, Stefania;
    • Pietrasanta, Daniela;
    • Marchetti, Monia;
    • Murru, Roberta;
    • Gentile, Massimo;
    • Rigolin, Gian Matteo;
    • Quaglia, Francesca Maria;
    • Scarfò, Lydia;
    • Sportoletti, Paolo;
    • Pravato, Stefano;
    • Piazza, Francesco;
    • Coscia, Marta;
    • Laurenti, Luca;
    • Molica, Stefano
    Publication type:
    Article
    15

    Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 322, doi. 10.1002/ajh.26447
    By:
    • Numan, Yazan;
    • Abdel Rahman, Zaid;
    • Grenet, Justin;
    • Boisclair, Stephanie;
    • Bewersdorf, Jan Philipp;
    • Collins, Cailin;
    • Barth, Dylan;
    • Fraga, Martina;
    • Bixby, Dale L.;
    • Zeidan, Amer M.;
    • Yilmaz, Musa;
    • Desai, Pankil;
    • Mannis, Gabriel;
    • Deutsch, Yehuda E.;
    • Abaza, Yasmin;
    • Dinner, Shira;
    • Frankfurt, Olga;
    • Litzow, Mark;
    • Al‐Kali, Aref;
    • Foran, James M.
    Publication type:
    Article
    16
    17

    Increased blood viscosity and red blood cell aggregation in patients with COVID‐19.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 283, doi. 10.1002/ajh.26440
    By:
    • Nader, Elie;
    • Nougier, Christophe;
    • Boisson, Camille;
    • Poutrel, Solene;
    • Catella, Judith;
    • Martin, Fiona;
    • Charvet, Juliette;
    • Girard, Sandrine;
    • Havard‐Guibert, Salomé;
    • Martin, Marie;
    • Rezigue, Hamdi;
    • Desmurs‐Clavel, Helene;
    • Renoux, Céline;
    • Joly, Philippe;
    • Guillot, Nicolas;
    • Bertrand, Yves;
    • Hot, Arnaud;
    • Dargaud, Yesim;
    • Connes, Philippe
    Publication type:
    Article
    18

    Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
    By:
    • Kaddoura, Marcella;
    • Binder, Moritz;
    • Dingli, David;
    • Buadi, Francis K.;
    • Lacy, Martha Q.;
    • Gertz, Morie A.;
    • Dispenzieri, Angela;
    • Kapoor, Prashant;
    • Hwa, Lisa;
    • Fonder, Amie;
    • Hobbs, Miriam;
    • Hayman, Suzanne;
    • Leung, Nelson;
    • Go, Ronald S.;
    • Lin, Yi;
    • Gonsalves, Wilson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Kyle, Robert A.;
    • Rajkumar, Vincent
    Publication type:
    Article
    19

    Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 274, doi. 10.1002/ajh.26442
    By:
    • Nagler, Arnon;
    • Labopin, Myriam;
    • Craddock, Charles;
    • Socié, Gerard;
    • Yakoub‐Agha, Ibrahim;
    • Gedde‐Dahl, Tobias;
    • Niittyvuopio, Riitta;
    • Byrne, Jennifer Louise;
    • Cornelissen, Jan J.;
    • Labussière‐Wallet, Hélène;
    • Arcese, William;
    • Milpied, Noel;
    • Esteve, Jordi;
    • Canaani, Jonathan;
    • Mohty, Mohamad
    Publication type:
    Article
    20

    Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 293, doi. 10.1002/ajh.26441
    By:
    • Abeykoon, Jithma P.;
    • Lasho, Terra L.;
    • Dasari, Surendra;
    • Rech, Karen L.;
    • Ranatunga, Wasantha K.;
    • Manske, Michelle K.;
    • Tischer, Alexander;
    • Ravindran, Aishwarya;
    • Young, Jason R.;
    • Tobin, William Oliver;
    • Flanagan, Eoin P.;
    • Nowakowski, Kevin E.;
    • Ruan, Gordon J.;
    • Shah, Mithun V.;
    • Bennani, Nabila Nora;
    • Vassallo, Robert;
    • Ryu, Jay H.;
    • Koster, Matthew J.;
    • Davidge‐Pitts, Caroline J.;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    21
    22
    23

    Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E83, doi. 10.1002/ajh.26434
    By:
    • Delimpasi, Sosana;
    • Mateos, Maria Victoria;
    • Auner, Holger W.;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.;
    • Quach, Hang;
    • Pylypenko, Halyna;
    • Hájek, Roman;
    • Leleu, Xavier;
    • Dolai, Tuphan Kanti;
    • Sinha, Dinesh Kumar;
    • Venner, Christopher P.;
    • Benjamin, Reuben;
    • Garg, Mamta Krishnan;
    • Doronin, Vadim;
    • Levy, Yair;
    • Moreau, Philippe;
    • Chai, Yi;
    • Arazy, Melina;
    • Shah, Jatin
    Publication type:
    Article
    24
    25

    Risk factors for severe COVID‐19 in hospitalized sickle cell disease patients: A study of 319 patients in France.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. E86, doi. 10.1002/ajh.26432
    By:
    • Arlet, Jean‐Benoît;
    • Lionnet, François;
    • Khimoud, Djamal;
    • Joseph, Laure;
    • de Montalembert, Mariane;
    • Morisset, Stéphane;
    • Garou, Alain;
    • Cannas, Giovanna;
    • Cougoul, Pierre;
    • Guitton, Corinne;
    • Holvoet, Laurent;
    • Odièvre, Marie‐Hélène;
    • Cheminet, Geoffrey;
    • Bartolucci, Pablo;
    • Santin, Aline;
    • Bernit, Emmanuelle;
    • de Luna, Gonzalo
    Publication type:
    Article
    26
    27

    Freeze‐dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 256, doi. 10.1002/ajh.26403
    By:
    • Ohanian, Maro;
    • Cancelas, Jose A.;
    • Davenport, Robertson;
    • Pullarkat, Vinod;
    • Hervig, Tor;
    • Broome, Catherine;
    • Marek, Kelly;
    • Kelly, Mary;
    • Gul, Zartash;
    • Rugg, Neeta;
    • Nestheide, Shawnagay;
    • Kinne, Bridget;
    • Szczepiorkowski, Zbigniew;
    • Kantarjian, Hagop;
    • Pehta, Joan;
    • Biehl, Ruth;
    • Yu, Anna;
    • Aung, Fleur;
    • Antebi, Ben;
    • Fitzpatrick, Glen Michael
    Publication type:
    Article
    28
    29
    30
    31

    Issue Information.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 3, p. 247, doi. 10.1002/ajh.26220
    Publication type:
    Article